International Journal of Drug Policy
Volume 16, Issue 3 , Pages 143-147, June 2005

Supporting the evidence-based treatment of individual drug users: The case for ‘patient profile decision analysis’

Keele Addiction Research Group, Department of Medicines Management, Keele University, Keele ST5 5BG, UK

Received 1 October 2003; received in revised form 17 December 2003; accepted 12 February 2004.

Abstract 

Practitioners treating problematic drug users face a significant challenge to (1) evaluate the evolving evidence base regarding treatment options, and (2) apply guidelines to individual patients with their unique combinations of characteristics, risks and histories. In this commentary we highlight patient profile decision analysis (PPDAS) as a rigorous and updateable means of assisting doctors deliver evidence-based care at a more patient focused level than current guidelines. PPDAS uses decision analytical modelling to calculate the evidence-based risks and benefits of different treatment options for multiple patient profiles. The output is presented in a user-friendly decision support system, enabling doctors and patients to quickly access the data to support their decision making. We outline the main features of PPDAS and review its potential for developing profile specific guidelines for the treatment of drug users.

Keywords: Decision analysis, Treatment guidelines, Decision support

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(04)00009-X

doi:10.1016/j.drugpo.2004.02.002

International Journal of Drug Policy
Volume 16, Issue 3 , Pages 143-147, June 2005